Initiation of anti-osteoporosis medication following hip fracture in older adults: a systematic review and thematic synthesis of qualitative studies from patient and healthcare professional perspectives.

ABSTRACT: Pharmacological osteoporosis treatment is recommended for secondary fracture prevention in older patients following a hip fracture. However, not all eligible patients receive anti-osteoporosis medication (AOMs). Understanding the decision-making process regarding treatment initiation at patient level may help explain low prescription rates and offer novel solutions beyond organisational initiatives. This systematic review aimed to synthesise data from qualitative studies on the initiation of AOMs after a hip fracture in old age, to (i) explore the experiences and preferences of patients and healthcare professionals in the decision-making process, and (ii) clarify if this explains low prescription rates. A systematic search in seven medical databases identified qualitative publications on t

SUBMITTER: de Jong-Holthuijsen S 

PROVIDER: S-EPMC12368851 | biostudies-literature | 2025 Aug

REPOSITORIES: biostudies-literature